药物微生物组学:一个新的领域,有助于优化帕金森病的药物治疗
Yi Zhang1, Chengjun Mo1, Penghui Ai1
1Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Gut microbes
|January 28, 2025
概括
肠道微生物群显著影响抗帕金森症药物的作用. 了解这种肠-大脑轴相互作用是开发个性化帕金森病治疗方法的关键,使用基于微生物群的策略.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 肠道微生物群影响药物的药理动力学,新陈代谢和疗效.
- 药物显著改变肠道微生物群的组成和功能.
- 新兴的药物微生物组学领域探索药物微生物群相互作用.
研究的目的:
- 提供肠道微生物群和抗帕金森症药物相互作用的历史概述.
- 探索对微生物群在药物代谢中的作用的机制性见解.
- 检查基于微生物群的生物标志物和优化帕金森病治疗的策略.
主要方法:
- 文献综述和现有研究的综合.
- 分析连接肠道微生物群和药物代谢的机制性途径.
- 对帕金森病目前基于微生物群的治疗策略的评估.
主要成果:
- 肠道微生物群是抗帕金森症药物的药理动力学和疗效的关键决定因素.
- 肠道微生物群和抗帕金森症药物之间存在复杂的双向通信.
- 基于微生物群的生物标志物显示出预测药物反应的潜力.
结论:
- 了解肠道微生物群与药物相互作用对于个性化的帕金森病治疗至关重要.
- 药理微观组学为新的治疗策略提供了基础.
- 准肠道微生物群可能会优化抗帕金森症药物治疗.
相关概念视频
01:24Parkinson's Disease: Treatment
194
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
194
01:15Parkinson's Disease: Overview
451
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
451
01:28Drug Therapy
37
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
37
01:27Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K